Date opened: July 2013
Date closed: December 2013
In the second half of 2013, the NIHR issued a call for research into the evaluation of public health measures, health care interventions and health services to reduce the development and spread of antimicrobial resistance and consequent morbidity. This call for research was part of a coordinated response by the NIHR to the publication of the 2nd volume of the 2011 Annual Report of the Chief Medical Officer: Infections and the rise of antimicrobial resistance. It also supports the Department of Health-led UK Antimicrobial Resistance Strategy which sets out how the challenges outlined in the report will be met.
This call was intended to cover all aspects of translational, clinical and public health research that could through new developments or changes in practice, contribute to a reduction in the development and spread in humans of organisms with antimicrobial resistance, and infection. Research may encompass better prevention, improved surveillance and monitoring and diagnosis as well as the more effective use of existing antibiotics, improved education and training and the development of new antimicrobial therapies and better treatment strategies.
The following NIHR-managed research programmes participated:
Efficacy and Mechanism Evaluation (EME)
Health Services and Delivery Research (HS&DR)
Health Technology Assessment (HTA)
Invention for Innovation (i4i)
Programme Grants for Applied Research (PGfAR)
Public Health Research (PHR)
Research for Patient Benefit (RfPB)
For more information on research funded in this area, please visit NIHR Open Data - antimicrobial resistance.